-
1
-
-
0035350810
-
Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes
-
Catanzarite V, Willms D, Wong D, Landers C, Cousins L, Schrimmer D. Acute respiratory distress syndrome in pregnancy and the puerperium: causes, courses, and outcomes. Obstet Gynecol 2001;97:760-4.
-
(2001)
Obstet Gynecol
, vol.97
, pp. 760-764
-
-
Catanzarite, V1
Willms, D2
Wong, D3
Landers, C4
Cousins, L5
Schrimmer, D.6
-
2
-
-
79953821466
-
Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic
-
Nair P, Davies AR, Beca J, Bellomo J, Ellwood D, Forrest P, et al. Extracorporeal membrane oxygenation for severe ARDS in pregnant and postpartum women during the 2009 H1N1 pandemic. Intensive Care Med 2011;37:648-54.
-
(2011)
Intensive Care Med
, vol.37
, pp. 648-654
-
-
Nair, P1
Davies, AR2
Beca, J3
Bellomo, J4
Ellwood, D5
Forrest, P6
-
3
-
-
84866504036
-
Lymphangioleiomyomatosis: newconcepts in pathogenesis, diagnosis, and treatment
-
Meraj R, Wikenheiser-Brokamp KA, Young LR, McCormack FX. Lymphangioleiomyomatosis: newconcepts in pathogenesis, diagnosis, and treatment. Semin Respir Crit Care Med 2012;33:486-97.
-
(2012)
Semin Respir Crit Care Med
, vol.33
, pp. 486-497
-
-
Meraj, R1
Wikenheiser-Brokamp, KA2
Young, LR3
McCormack, FX.4
-
4
-
-
62949239839
-
Pregnancy experiences among women with lymphangioleiomyomatosis
-
Cohen MM, Freyer AM, Johnson SR. Pregnancy experiences among women with lymphangioleiomyomatosis. Respir Med 2009;103:766-72.
-
(2009)
Respir Med
, vol.103
, pp. 766-772
-
-
Cohen, MM1
Freyer, AM2
Johnson, SR.3
-
5
-
-
0034121340
-
Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study
-
Matsui K, Takeda K, Yu ZX, Valencia J, Travis WD, Moss J, et al. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 2000;161:1002-9.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 1002-1009
-
-
Matsui, K1
Takeda, K2
Yu, ZX3
Valencia, J4
Travis, WD5
Moss, J6
-
6
-
-
77956799312
-
Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases
-
Young LR, Vandyke R, Gulleman PM. Serum vascular endothelial growth factor-D prospectively distinguishes lymphangioleiomyomatosis from other diseases. Chest 2010;138:674-81.
-
(2010)
Chest
, vol.138
, pp. 674-681
-
-
Young, LR1
Vandyke, R2
Gulleman, PM.3
-
7
-
-
79955510505
-
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
-
McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. National Institutes of Health Rare Lung Diseases Consortium, MILES Trial Group. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. NEJM 2011;364:1595-606.
-
(2011)
NEJM
, vol.364
, pp. 1595-1606
-
-
McCormack, FX1
Inoue, Y2
Moss, J3
Singer, LG4
Strange, C5
Nakata, K6
-
8
-
-
33846849169
-
Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage
-
Heslett L, Nielsen JD, Levi M, Sengelov H, Johansson PI. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care 2006;10: R177.
-
(2006)
Crit Care
, vol.10
, pp. R177
-
-
Heslett, L1
Nielsen, JD2
Levi, M3
Sengelov, H4
Johansson, PI.5
|